ASML vs. Taiwan Semiconductor Manufacturing: Which Tech Stock Is a Better Buy in 2026?

ASML generated fiscal 2025 revenue of approximately $37.9 billion (+15.6% YoY), net income of $11.1 billion and $12.3 billion of free cash flow, supported by its monopoly in EUV lithography systems used for advanced AI chips. TSMC delivered faster growth and higher profitability, with $121.8 billion of revenue (+33% YoY), $54.9 billion of net income, a 45.1% net margin and $34.7 billion of free cash flow; it also trades at a lower forward P/E of 25.3x versus ASML's 38.6x. The article nevertheless favors ASML for its monopoly-driven pricing power, while flagging export restrictions as its key risk and geopolitical concentration, capital intensity, and Intel/Samsung competition as key risks for TSMC.

Analysis

The relevant distinction is not monopoly versus competition, but earnings duration versus earnings visibility. ASML’s valuation embeds sustained EUV/High-NA tool conversion and a benign export-control regime; its backlog can mask a weaker mix or customer deferrals until shipment acceptance. TSM’s lower multiple leaves more room for upside if leading-edge wafer pricing and utilization remain firm through the N2 ramp, while its scale converts AI demand into recurring wafer volume rather than lumpy equipment orders.

A second-order beneficiary of TSM capacity tightness is NVDA: constrained leading-edge supply supports disciplined accelerator availability and pricing, but an easing of TSM bottlenecks would shift value toward cloud customers and custom-silicon designers rather than foundry margins. Intel’s foundry investment is not yet a near-term threat to TSM economics; it is more immediately a capital-intensity and execution risk for INTC. The market should demand evidence of external customer commitments and yield parity before assigning meaningful competitive share transfer.

Near term, both stocks are exposed to an AI capex digestion narrative, but ASML is more vulnerable to a multiple reset because the premium rests on long-dated technology scarcity. Over 6-18 months, TSM’s principal non-fundamental discount remains Taiwan-tail-risk; any easing in cross-strait rhetoric or incremental overseas-capacity qualification could catalyze rerating. The relative thesis fails if TSM’s advanced-node utilization or gross-margin outlook deteriorates materially, or if ASML demonstrates faster-than-expected High-NA bookings and service-margin expansion without incremental export restrictions.

Key Decisions for Investors

• Initiate a 3-6 month relative-value position: long TSM / short ASML, dollar-neutral. Target 10-15% relative return from TSM multiple catch-up and lower sensitivity to a High-NA shipment delay; stop if TSM cuts advanced-node margin guidance or ASML raises forward order-book commentary materially.
• Maintain NVDA as the preferred downstream AI exposure rather than adding INTC on foundry optionality. Reassess only after INTC discloses a material third-party foundry contract, credible leading-node yield data, and capex funding that does not require further balance-sheet stress.
• Use ASML pullbacks tied solely to broad semiconductor risk-off as a long-term accumulation watch item, not an immediate chase. Require confirmation that export-control restrictions are not reducing shipment mix and that High-NA customer acceptance remains on schedule before paying the current scarcity premium.
• Set event alerts around TSM monthly revenue, quarterly utilization/gross-margin guidance, ASML bookings and shipment acceptance, and any US/Dutch/Japanese export-control changes. A negative policy surprise is a days-to-weeks risk for ASML; worsening Taiwan risk premiums are the key hedge trigger for TSM exposure.